» Articles » PMID: 26773472

Case-based Educational Intervention to Assess Change in Providers' Knowledge and Attitudes Towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 2016 Jan 17
PMID 26773472
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Prior studies have shown provider-level knowledge gaps regarding the 2013 American College of Cardiology/American Heart Association guideline on the treatment of cholesterol and concerns about 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimation. The effect of an educational intervention to mitigate knowledge gaps is unknown.

Methods: We developed a questionnaire and administered it to providers before (pre-training) and after (post-training) a case-based educational intervention across 6 sites in Texas. The intervention highlighted the key recommendations of the 2013 guideline and the differences from the prior guideline mainly using clinical-vignettes. Several practice pertinent items were also discussed.

Results: Most participants were providers-in-training (78%) in internal medicine (68%). Compared to pre-training, the post-training metrics were: 43% vs. 82% for providers' ability to identify 4 statin benefit groups; 47% vs. 97% for their awareness of the ASCVD risk threshold of ≥ 7.5% to initiate discussion about risks/benefits of statin therapy; 9% vs. 40% for awareness of differences between the Framingham and the ASCVD risk estimator; 26% vs. 78% for awareness of the definition of statin intensity; 35% vs. 62% for using a repeat lipid panel to document treatment response and adherence; and 46% vs. 81% for confidence in using the ASCVD risk estimator, respectively.

Conclusions: A case-based educational intervention was associated with significant increase in providers' knowledge towards the 2013 cholesterol guideline, which could be related to the engaging nature of our intervention, using practice pertinent information and clinical vignettes. Such interventions could be useful in effective dissemination of the cholesterol guideline.

Citing Articles

The Impact of an Educational Intervention on Enhancing Clinical Knowledge of Physicians and Pharmacists Regarding Statins and Monitoring Parameters: The Experience of a Tertiary Teaching Hospital.

Al-Ashwal F, Syed Sulaiman S, Sheikh Ghadzi S, Harun S, Halboup A, Kubas M Adv Med Educ Pract. 2024; 15:357-368.

PMID: 38707544 PMC: 11069367. DOI: 10.2147/AMEP.S445610.


Physicians and pharmacists' clinical knowledge of statin therapy and monitoring parameters, and the barriers to guideline implementation in clinical practice.

Al-Ashwal F, Syed Sulaiman S, Sheikh Ghadzi S, Kubas M, Halboup A PLoS One. 2023; 18(1):e0280432.

PMID: 36662695 PMC: 9858478. DOI: 10.1371/journal.pone.0280432.


GPs' familiarity with and use of cardiovascular clinical prediction rules: a UK survey study.

Ban J, Perera R, Stevens R BJGP Open. 2020; 4(5).

PMID: 33023870 PMC: 7880194. DOI: 10.3399/bjgpopen20X101081.


Nurse Practitioner Knowledge of Symptoms of Acute Coronary Syndrome.

Davis L, Maness J J Nurse Pract. 2019; 15(1):e9-e12.

PMID: 31354392 PMC: 6660173. DOI: 10.1016/j.nurpra.2018.09.017.


Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry).

Lowenstern A, Navar A, Li S, Virani S, Goldberg A, Louie M Am J Cardiol. 2019; 123(7):1011-1018.

PMID: 30660354 PMC: 6526057. DOI: 10.1016/j.amjcard.2018.12.031.


References
1.
OBrien M, Rogers S, Jamtvedt G, Oxman A, Odgaard-Jensen J, Kristoffersen D . Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007; (4):CD000409. PMC: 7032679. DOI: 10.1002/14651858.CD000409.pub2. View

2.
Pursnani A, Mayrhofer T, Ferencik M, Hoffmann U . The 2013 ACC/AHA cardiovascular prevention guidelines improve alignment of statin therapy with coronary atherosclerosis as detected by coronary computed tomography angiography. Atherosclerosis. 2014; 237(1):314-8. PMC: 5939942. DOI: 10.1016/j.atherosclerosis.2014.09.023. View

3.
Virani S, Steinberg L, Murray T, Negi S, Nambi V, Woodard L . Barriers to non-HDL cholesterol goal attainment by providers. Am J Med. 2011; 124(9):876-80.e2. PMC: 4180871. DOI: 10.1016/j.amjmed.2011.02.012. View

4.
Cabana M, Rand C, Powe N, Wu A, Wilson M, Abboud P . Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999; 282(15):1458-65. DOI: 10.1001/jama.282.15.1458. View

5.
Yeboah J, Sillau S, Delaney J, Blaha M, Michos E, Young R . Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2015; 169(3):387-395.e3. PMC: 4347939. DOI: 10.1016/j.ahj.2014.12.018. View